Sunday, September 6, 2026 See who Washington just made rich Get the free brief →
Money Racket
Who Cashes In When Washington Moves
HEALTHCARE & FDAFDA Approves Camizestrant for ESR1+ Breast CanceryesterdayHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma4 weeks agoHEALTHCARE & FDAFDA Acts to Prevent Neonatal Nutrition Supply ShortageyesterdayTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout4 weeks agoHEALTHCARE & FDAFDA Seeks Input on Botanical Drug PathwaysyesterdayTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing4 weeks agoHEALTHCARE & FDAFDA Authorizes Screwworm Prevention for PetsyesterdayWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers4 weeks agoMARKETSCFTC Clears CAD and MXN Swap TransitionsyesterdayENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes4 weeks agoENERGYEPA Extends RFS Reporting Deadline One Month2 days agoDEFENSEPentagon Awards Space-Based Target Tracking Contracts4 weeks agoHEALTHCARE & FDAFDA Approves First Alexander Disease Drug2 days agoTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio4 weeks agoWHITE HOUSEFinCEN Tightens Southwest Border Money Reporting2 days agoWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty4 weeks agoDEFENSEPratt & Whitney Engine Flaw Drives MRO Workload3 days agoDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains4 weeks agoDEFENSEAirbus Landing Gear Flaw Expands MRO Workload3 days agoWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shift4 weeks agoTECHDHS Awards AWS $60M Cloud Hosting Deal3 days agoWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacing4 weeks agoWHITE HOUSEGardaWorld Wins $100M ICE Armed Transport Deal3 days agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidance4 weeks agoENERGYNASA Awards Sierra Lobo $77M for Space Reactor3 days agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Cask4 weeks agoTECHAccenture Wins $30M DOE Modernization Contract4 days agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestock4 weeks agoDEFENSETrump Scales Back Korea Exercises—Defense Contractors Face Uncertainty4 days agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contract3 weeks agoWHITE HOUSETrump Bans Foreign Grid Equipment—US Suppliers Win4 days agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibility3 weeks agoENERGYDOE Stays Clean Energy Building Rules—Fossil Fuel Lobby Wins Reprieve4 days agoDEFENSEBlackSky Lands Multi-Year Satellite Contract3 weeks agoHEALTHCARE & FDAFDA Approves Lisraya for Dermatomyositis—Rare-Disease Win5 days agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Wins3 weeks agoMARKETSFDIC Eases Reciprocal Deposit Rules—Bank Funding Win5 days agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makers3 weeks agoMARKETSFTC Sues Amazon Over Ad Auction Manipulation—Antitrust5 days agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refund3 weeks agoENERGYTrump Admin Fast-Tracks Alaska Oil Pipeline—Energy Win5 days agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persists3 weeks agoCRYPTOSEC Proposes Tailored Crypto Offering Rules—Clarity Win5 days agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings3 weeks agoDEFENSEBoeing Wins $131B F-15 Contract—Fighter Jet Dominance6 days agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Path3 weeks agoCRYPTOSEC Proposes Crypto Offering Exemptions—Regulatory Clarity6 days agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boost3 weeks agoENERGYCentrus HALEU Enrichment Wins Policy Tailwind—Nuclear Fuel6 days agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressure3 weeks agoHEALTHCARE & FDAWhat Is a PDUFA Date?6 days agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demand3 weeks agoMARKETSWhat Is a Negotiated Price6 days agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Eases3 weeks agoHEALTHCARE & FDAFDA Approves Mimrylo for Polycythemia Veralast weekDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfall3 weeks agoHEALTHCARE & FDAFDA Authorizes Generic Bimectin for Screwworm Preventionlast weekHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopoly3 weeks agoHEALTHCARE & FDAFDA Opens GenAI Medical Device Regulation to Public Inputlast weekHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnostics3 weeks agoHEALTHCARE & FDATrump Admin Blocks $1.6B in Fraudulent Medicare Lab Paymentslast weekTECHCommerce Eases Drone Export Rules—U.S. Makers Win3 weeks agoTECHNHTSA Extends Comment Period on Vehicle Safety Exemptionslast weekDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervalued3 weeks agoENERGYBLM Launches 30-Year Permit for Trans-Alaska Pipeline Operationslast weekENERGYNewsom Passes Diablo Canyon Decision to Successor2 weeks agoMARKETSFTC Blocks Henkel's $725M Liquid Nails Bid—Antitrust Winslast weekHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpayment2 weeks agoHEALTHCARE & FDAFDA Approves First RAS Inhibitor for Pancreatic Cancerlast weekWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. Persons2 weeks agoDEFENSEBoeing Lands $131B F-15 Contract—Fighter Jet Dominancelast weekENERGYFederal Court Orders Enbridge Line 5 Removal2 weeks agoHEALTHCARE & FDACostco Enters Medicare Advantage—Retail Disruption Loomslast weekENERGYEnbridge Wins Federal Permit for Line 5 Tunnel2 weeks agoTRADE & TARIFFSTrump's 50% Canada Tariffs Take Effect—Retailers Bracelast weekTECHD-Wave Wins Canadian Quantum Funding for Annealing2 weeks agoTRADE & TARIFFSU.S. Rolls Out Iran Sanctions—Oil Prices Sliplast weekHEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma Demand2 weeks agoHEALTHCARE & FDAAbbott's Dual Glucose-Ketone Monitor Wins FDA Nodlast weekTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings2 weeks agoHEALTHCARE & FDARegeneron's Gene Therapy Wins First GSD Type Ia Approvallast weekDEFENSEFAA Engine Inspection Order Lifts MRO Stocks2 weeks agoDEFENSEStryker Lands $100M Defense Contract—Combat Vehicle Boostlast weekTECHUtah Governor Signs Quantum Computing Initiative Orderlast weekTRADE & TARIFFSWalmart Deploys $2.9B Tariff Refund Into Price Cutslast weekTRADE & TARIFFSTrump Administration Targets Iran's Banking System With New Sanctionslast weekTRADE & TARIFFSTrump Lifts Ground Beef Tariffs—Ranchers Face Price Pressurelast weekTECHCHIPS Act Transforms Binghamton Into Semiconductor Hublast weekWHITE HOUSETrump Kills Affirmative Action Rules—Contractors Face Compliance Shiftlast weekWHITE HOUSELabor Dept Eases Veteran Hiring Rules—Contractors Cut Compliancelast weekHEALTHCARE & FDAFDA Clears Robotic Blood Draw—Phlebotomy Shortage Easeslast weekWHITE HOUSELabor Dept Eases Disability Hiring Rules—Contractors Save Compliance Costslast week
Tech

Bosch's $225M CHIPS Act Award for Roseville Chips Away at U.S. Dependence on Asian Auto Semiconductors

Federal money flowing to Bosch's California fab targets automotive chips specifically — a supply chain gap that burned Detroit in 2021 and hasn't fully healed.

Image: Money Racket
By at Money Racket · Jul 22, 2026

Bosch announced a $225 million direct funding agreement with the U.S. Department of Commerce as part of a broader $2 billion investment in its Roseville, California semiconductor facility. The CHIPS Act award targets automotive-grade semiconductors, the exact category that caused the global auto production shutdown in 2021-2022 when Asian fab capacity was unavailable.

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

The 2021 auto chip shortage cost Detroit billions — Bosch's Roseville fab is the insurance policy, and Applied Materials sells the equipment to build it.

Who cashes in: Bosch is private and German-headquartered, so there's no direct ticker. The domestic beneficiaries are the equipment suppliers that will outfit the Roseville expansion. Lam Research LRCX, Applied Materials AMAT, and KLA Corporation KLAC are the three dominant U.S.-listed semiconductor equipment makers that supply fabs of this type — any major fab buildout generates equipment orders that flow to this group. Entegris (ENTG) supplies specialty chemicals and materials to semiconductor fabs and benefits from domestic capacity additions. On the automotive side, Ford F and GM (GM) are the downstream winners if domestic automotive chip supply becomes more reliable and less subject to Asian geopolitical disruption.

Who's exposed: Taiwan Semiconductor (TSM, U.S.-listed ADR) and other Asian foundries that currently supply automotive chips to U.S. OEMs face gradual market share erosion as domestic capacity comes online — though the timeline is years, not quarters. NXP Semiconductors (NXPI) and Infineon (IFNNY) are the dominant automotive chip designers; they're not threatened by Bosch's fab expansion since Bosch primarily makes chips for its own use.

What to watch next: Whether the remaining CHIPS Act funding pipeline continues to flow or gets caught in the political crossfire referenced in recent commentary about Trump's attacks on the program. Equipment order announcements from AMAT or LRCX tied to Roseville would confirm the capital spending is real.

Source: original report ↗

Knowing who cashed in is only half the trade.

Every catalyst has a second move — the supplier, the sector, the part already priced in. Money Racket Pro hands you that read on every policy event, plus the pre-market brief six mornings a week, before the open.

Get the edge · $40/mo

Join the readers who get there before the financial press. Cancel anytime, one click.

Share

https://moneyracket.com/article/bosch-chips-act-225-million-roseville-semiconductor/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Get the free brief The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Get the free brief →